title: Infliximab-induced vitiligo.
authors.forename: Mercedes
authors.initials: M
authors.lastname: Ramírez-Hernández
authors.forename: Carlos
authors.initials: C
authors.lastname: Marras
authors.forename: Jorge A
authors.initials: JA
authors.lastname: Martínez-Escribano
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003937:Diagnosis, Differential; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014820:Vitiligo / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab